Jinguo Zhang

Hefei, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Repurposing AZD-7762 as a novel direct NLRP3 inhibitor for the treatment of inflammatory diseases.

Repurposing AZD-7762 as a novel direct NLRP3 inhibitor for the treatment of inflammatory diseases.

Journal: International immunopharmacology
Published: April 13, 2026

SIK2 activates the autophagy‒apoptosis pathway through SP1 regulation to inhibit the progression of hepatocellular carcinoma.

SIK2 activates the autophagy‒apoptosis pathway through SP1 regulation to inhibit the progression of hepatocellular carcinoma.

Journal: Frontiers in pharmacology
Published: May 27, 2025

BRD4 orchestrates the metabolic-epigenetic regulation of GM-CSF expression and secretion to drive PD-L1⁺ macrophage-mediated immune evasion in triple-negative breast cancer.

BRD4 orchestrates the metabolic-epigenetic regulation of GM-CSF expression and secretion to drive PD-L1⁺ macrophage-mediated immune evasion in triple-negative breast cancer.

Journal: Oncogene
Published: March 13, 2025

Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis.

Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis.

Journal: Breast cancer research : BCR
Published: March 03, 2025

Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.

Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment.

Journal: Molecular cancer
Published: December 03, 2024

CD1B Expression in Triple-Negative Breast Cancer: Its Implications for Prognosis and Immunotherapy Outcomes.

CD1B Expression in Triple-Negative Breast Cancer: Its Implications for Prognosis and Immunotherapy Outcomes.

Journal: Current gene therapy
Published: October 15, 2024

COL4A1 Promotes Gastric Cancer Progression by Regulating Tumor Invasion, Tumor Microenvironment and Drug Sensitivity.

COL4A1 Promotes Gastric Cancer Progression by Regulating Tumor Invasion, Tumor Microenvironment and Drug Sensitivity.

Journal: Current medicinal chemistry
Published: September 10, 2024

LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer.

LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer.

Journal: BMC immunology
Published: March 13, 2024

Increased ACSL6 Expression Predicts a Favorable Prognosis in Triple-negative Breast Cancer.

Increased ACSL6 Expression Predicts a Favorable Prognosis in Triple-negative Breast Cancer.

Journal: Current medicinal chemistry
Published: September 10, 2023

ANO10 is a potential prognostic biomarker and correlates with immune infiltration in breast cancer.

ANO10 is a potential prognostic biomarker and correlates with immune infiltration in breast cancer.

Journal: American journal of cancer research
Published: January 05, 2023

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment.

Journal: Frontiers in immunology
Published: October 18, 2022

Systematic Investigation of the Multifaceted Role of SOX11 in Cancer.

Systematic Investigation of the Multifaceted Role of SOX11 in Cancer.

Journal: Cancers
Published: October 04, 2022
Showing 1-12 of 20

Last Updated: 09/26/2026